Pharma & Healthcare
Oral Antidiabetic Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 548688
- Pages: 106
- Figures: 186
- Views: 1
Oral antidiabetic drugs are medications used to manage blood glucose levels in individuals with type 2 diabetes. They work by improving insulin sensitivity, increasing insulin production, or reducing glucose production in the liver.
The global market for Oral Antidiabetic Drugs was estimated to be worth US$ 1844 million in 2023 and is forecast to a readjusted size of US$ 2236.3 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
The market for oral antidiabetic drugs is driven by the growing prevalence of type 2 diabetes and the need for effective and convenient glucose-lowering medications. The market's growth is also influenced by ongoing research in diabetes therapeutics, leading to the development of new drug classes and combination therapies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oral Antidiabetic Drugs by region & country, by Type, and by Application.
The Oral Antidiabetic Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Drugs.
Market Segmentation
By Company
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Huadong Medicine Co.,Ltd.
Lepu Medical
Hengrui Medicine
Segment by Type:
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Antidiabetic Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oral Antidiabetic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oral Antidiabetic Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Oral Antidiabetic Drugs was estimated to be worth US$ 1844 million in 2023 and is forecast to a readjusted size of US$ 2236.3 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
The market for oral antidiabetic drugs is driven by the growing prevalence of type 2 diabetes and the need for effective and convenient glucose-lowering medications. The market's growth is also influenced by ongoing research in diabetes therapeutics, leading to the development of new drug classes and combination therapies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oral Antidiabetic Drugs by region & country, by Type, and by Application.
The Oral Antidiabetic Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Drugs.
Market Segmentation
By Company
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Huadong Medicine Co.,Ltd.
Lepu Medical
Hengrui Medicine
Segment by Type:
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Antidiabetic Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oral Antidiabetic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oral Antidiabetic Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Oral Antidiabetic Drugs Product Introduction
1.2 Global Oral Antidiabetic Drugs Market Size Forecast
1.3 Oral Antidiabetic Drugs Market Trends & Drivers
1.3.1 Oral Antidiabetic Drugs Industry Trends
1.3.2 Oral Antidiabetic Drugs Market Drivers & Opportunity
1.3.3 Oral Antidiabetic Drugs Market Challenges
1.3.4 Oral Antidiabetic Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oral Antidiabetic Drugs Players Revenue Ranking (2023)
2.2 Global Oral Antidiabetic Drugs Revenue by Company (2019-2024)
2.3 Key Companies Oral Antidiabetic Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oral Antidiabetic Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Oral Antidiabetic Drugs
2.6 Oral Antidiabetic Drugs Market Competitive Analysis
2.6.1 Oral Antidiabetic Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oral Antidiabetic Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sulfonylureas
3.1.2 Meglitinides
3.1.3 Alpha-glucosidase inhibitors
3.2 Global Oral Antidiabetic Drugs Sales Value by Type
3.2.1 Global Oral Antidiabetic Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oral Antidiabetic Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Oral Antidiabetic Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Oral Antidiabetic Drugs Sales Value by Application
4.2.1 Global Oral Antidiabetic Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oral Antidiabetic Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Oral Antidiabetic Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oral Antidiabetic Drugs Sales Value by Region
5.1.1 Global Oral Antidiabetic Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024)
5.1.3 Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030)
5.1.4 Global Oral Antidiabetic Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oral Antidiabetic Drugs Sales Value, 2019-2030
5.2.2 North America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oral Antidiabetic Drugs Sales Value, 2019-2030
5.3.2 Europe Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oral Antidiabetic Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oral Antidiabetic Drugs Sales Value, 2019-2030
5.5.2 South America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oral Antidiabetic Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oral Antidiabetic Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oral Antidiabetic Drugs Sales Value
6.3 United States
6.3.1 United States Oral Antidiabetic Drugs Sales Value, 2019-2030
6.3.2 United States Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oral Antidiabetic Drugs Sales Value, 2019-2030
6.4.2 Europe Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oral Antidiabetic Drugs Sales Value, 2019-2030
6.5.2 China Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oral Antidiabetic Drugs Sales Value, 2019-2030
6.6.2 Japan Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oral Antidiabetic Drugs Sales Value, 2019-2030
6.7.2 South Korea Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oral Antidiabetic Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oral Antidiabetic Drugs Sales Value, 2019-2030
6.9.2 India Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Profile
7.1.2 Eli Lilly Main Business
7.1.3 Eli Lilly Oral Antidiabetic Drugs Products, Services and Solutions
7.1.4 Eli Lilly Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Eli Lilly Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Oral Antidiabetic Drugs Products, Services and Solutions
7.2.4 Abbott Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Biocon
7.3.1 Biocon Profile
7.3.2 Biocon Main Business
7.3.3 Biocon Oral Antidiabetic Drugs Products, Services and Solutions
7.3.4 Biocon Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Sanofi Recent Developments
7.4 Sanofi
7.4.1 Sanofi Profile
7.4.2 Sanofi Main Business
7.4.3 Sanofi Oral Antidiabetic Drugs Products, Services and Solutions
7.4.4 Sanofi Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Sanofi Recent Developments
7.5 Sunpharma
7.5.1 Sunpharma Profile
7.5.2 Sunpharma Main Business
7.5.3 Sunpharma Oral Antidiabetic Drugs Products, Services and Solutions
7.5.4 Sunpharma Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Sunpharma Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Oral Antidiabetic Drugs Products, Services and Solutions
7.6.4 Novartis Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Profile
7.7.2 Novo Nordisk Main Business
7.7.3 Novo Nordisk Oral Antidiabetic Drugs Products, Services and Solutions
7.7.4 Novo Nordisk Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Novo Nordisk Recent Developments
7.8 Merck
7.8.1 Merck Profile
7.8.2 Merck Main Business
7.8.3 Merck Oral Antidiabetic Drugs Products, Services and Solutions
7.8.4 Merck Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Merck Recent Developments
7.9 Pfizer
7.9.1 Pfizer Profile
7.9.2 Pfizer Main Business
7.9.3 Pfizer Oral Antidiabetic Drugs Products, Services and Solutions
7.9.4 Pfizer Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Pfizer Recent Developments
7.10 Huadong Medicine Co.,Ltd.
7.10.1 Huadong Medicine Co.,Ltd. Profile
7.10.2 Huadong Medicine Co.,Ltd. Main Business
7.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Products, Services and Solutions
7.10.4 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Huadong Medicine Co.,Ltd. Recent Developments
7.11 Lepu Medical
7.11.1 Lepu Medical Profile
7.11.2 Lepu Medical Main Business
7.11.3 Lepu Medical Oral Antidiabetic Drugs Products, Services and Solutions
7.11.4 Lepu Medical Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Lepu Medical Recent Developments
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Profile
7.12.2 Hengrui Medicine Main Business
7.12.3 Hengrui Medicine Oral Antidiabetic Drugs Products, Services and Solutions
7.12.4 Hengrui Medicine Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.12.5 Hengrui Medicine Recent Developments
8 Industry Chain Analysis
8.1 Oral Antidiabetic Drugs Industrial Chain
8.2 Oral Antidiabetic Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oral Antidiabetic Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Oral Antidiabetic Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Oral Antidiabetic Drugs Product Introduction
1.2 Global Oral Antidiabetic Drugs Market Size Forecast
1.3 Oral Antidiabetic Drugs Market Trends & Drivers
1.3.1 Oral Antidiabetic Drugs Industry Trends
1.3.2 Oral Antidiabetic Drugs Market Drivers & Opportunity
1.3.3 Oral Antidiabetic Drugs Market Challenges
1.3.4 Oral Antidiabetic Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oral Antidiabetic Drugs Players Revenue Ranking (2023)
2.2 Global Oral Antidiabetic Drugs Revenue by Company (2019-2024)
2.3 Key Companies Oral Antidiabetic Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oral Antidiabetic Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Oral Antidiabetic Drugs
2.6 Oral Antidiabetic Drugs Market Competitive Analysis
2.6.1 Oral Antidiabetic Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oral Antidiabetic Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sulfonylureas
3.1.2 Meglitinides
3.1.3 Alpha-glucosidase inhibitors
3.2 Global Oral Antidiabetic Drugs Sales Value by Type
3.2.1 Global Oral Antidiabetic Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oral Antidiabetic Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Oral Antidiabetic Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Oral Antidiabetic Drugs Sales Value by Application
4.2.1 Global Oral Antidiabetic Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oral Antidiabetic Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Oral Antidiabetic Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oral Antidiabetic Drugs Sales Value by Region
5.1.1 Global Oral Antidiabetic Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024)
5.1.3 Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030)
5.1.4 Global Oral Antidiabetic Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oral Antidiabetic Drugs Sales Value, 2019-2030
5.2.2 North America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oral Antidiabetic Drugs Sales Value, 2019-2030
5.3.2 Europe Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oral Antidiabetic Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oral Antidiabetic Drugs Sales Value, 2019-2030
5.5.2 South America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oral Antidiabetic Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oral Antidiabetic Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oral Antidiabetic Drugs Sales Value
6.3 United States
6.3.1 United States Oral Antidiabetic Drugs Sales Value, 2019-2030
6.3.2 United States Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oral Antidiabetic Drugs Sales Value, 2019-2030
6.4.2 Europe Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oral Antidiabetic Drugs Sales Value, 2019-2030
6.5.2 China Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oral Antidiabetic Drugs Sales Value, 2019-2030
6.6.2 Japan Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oral Antidiabetic Drugs Sales Value, 2019-2030
6.7.2 South Korea Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oral Antidiabetic Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oral Antidiabetic Drugs Sales Value, 2019-2030
6.9.2 India Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oral Antidiabetic Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Profile
7.1.2 Eli Lilly Main Business
7.1.3 Eli Lilly Oral Antidiabetic Drugs Products, Services and Solutions
7.1.4 Eli Lilly Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Eli Lilly Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Oral Antidiabetic Drugs Products, Services and Solutions
7.2.4 Abbott Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Biocon
7.3.1 Biocon Profile
7.3.2 Biocon Main Business
7.3.3 Biocon Oral Antidiabetic Drugs Products, Services and Solutions
7.3.4 Biocon Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Sanofi Recent Developments
7.4 Sanofi
7.4.1 Sanofi Profile
7.4.2 Sanofi Main Business
7.4.3 Sanofi Oral Antidiabetic Drugs Products, Services and Solutions
7.4.4 Sanofi Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Sanofi Recent Developments
7.5 Sunpharma
7.5.1 Sunpharma Profile
7.5.2 Sunpharma Main Business
7.5.3 Sunpharma Oral Antidiabetic Drugs Products, Services and Solutions
7.5.4 Sunpharma Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Sunpharma Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Oral Antidiabetic Drugs Products, Services and Solutions
7.6.4 Novartis Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Profile
7.7.2 Novo Nordisk Main Business
7.7.3 Novo Nordisk Oral Antidiabetic Drugs Products, Services and Solutions
7.7.4 Novo Nordisk Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Novo Nordisk Recent Developments
7.8 Merck
7.8.1 Merck Profile
7.8.2 Merck Main Business
7.8.3 Merck Oral Antidiabetic Drugs Products, Services and Solutions
7.8.4 Merck Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Merck Recent Developments
7.9 Pfizer
7.9.1 Pfizer Profile
7.9.2 Pfizer Main Business
7.9.3 Pfizer Oral Antidiabetic Drugs Products, Services and Solutions
7.9.4 Pfizer Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Pfizer Recent Developments
7.10 Huadong Medicine Co.,Ltd.
7.10.1 Huadong Medicine Co.,Ltd. Profile
7.10.2 Huadong Medicine Co.,Ltd. Main Business
7.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Products, Services and Solutions
7.10.4 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Huadong Medicine Co.,Ltd. Recent Developments
7.11 Lepu Medical
7.11.1 Lepu Medical Profile
7.11.2 Lepu Medical Main Business
7.11.3 Lepu Medical Oral Antidiabetic Drugs Products, Services and Solutions
7.11.4 Lepu Medical Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Lepu Medical Recent Developments
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Profile
7.12.2 Hengrui Medicine Main Business
7.12.3 Hengrui Medicine Oral Antidiabetic Drugs Products, Services and Solutions
7.12.4 Hengrui Medicine Oral Antidiabetic Drugs Revenue (US$ Million) & (2019-2024)
7.12.5 Hengrui Medicine Recent Developments
8 Industry Chain Analysis
8.1 Oral Antidiabetic Drugs Industrial Chain
8.2 Oral Antidiabetic Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oral Antidiabetic Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Oral Antidiabetic Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oral Antidiabetic Drugs Market Trends
Table 2. Oral Antidiabetic Drugs Market Drivers & Opportunity
Table 3. Oral Antidiabetic Drugs Market Challenges
Table 4. Oral Antidiabetic Drugs Market Restraints
Table 5. Global Oral Antidiabetic Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oral Antidiabetic Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oral Antidiabetic Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oral Antidiabetic Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Oral Antidiabetic Drugs
Table 10. Global Oral Antidiabetic Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oral Antidiabetic Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oral Antidiabetic Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oral Antidiabetic Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oral Antidiabetic Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oral Antidiabetic Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oral Antidiabetic Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oral Antidiabetic Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oral Antidiabetic Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oral Antidiabetic Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oral Antidiabetic Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly Basic Information List
Table 32. Eli Lilly Description and Business Overview
Table 33. Eli Lilly Oral Antidiabetic Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Eli Lilly (2019-2024)
Table 35. Eli Lilly Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Oral Antidiabetic Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Biocon Basic Information List
Table 42. Biocon Description and Business Overview
Table 43. Biocon Oral Antidiabetic Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Biocon (2019-2024)
Table 45. Biocon Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Oral Antidiabetic Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Sanofi (2019-2024)
Table 50. Sanofi Recent Developments
Table 51. Sunpharma Basic Information List
Table 52. Sunpharma Description and Business Overview
Table 53. Sunpharma Oral Antidiabetic Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Sunpharma (2019-2024)
Table 55. Sunpharma Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Oral Antidiabetic Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Novo Nordisk Basic Information List
Table 62. Novo Nordisk Description and Business Overview
Table 63. Novo Nordisk Oral Antidiabetic Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Novo Nordisk (2019-2024)
Table 65. Novo Nordisk Recent Developments
Table 66. Merck Basic Information List
Table 67. Merck Description and Business Overview
Table 68. Merck Oral Antidiabetic Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Merck (2019-2024)
Table 70. Merck Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Oral Antidiabetic Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. Huadong Medicine Co.,Ltd. Basic Information List
Table 77. Huadong Medicine Co.,Ltd. Description and Business Overview
Table 78. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Huadong Medicine Co.,Ltd. (2019-2024)
Table 80. Huadong Medicine Co.,Ltd. Recent Developments
Table 81. Lepu Medical Basic Information List
Table 82. Lepu Medical Description and Business Overview
Table 83. Lepu Medical Oral Antidiabetic Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Lepu Medical (2019-2024)
Table 85. Lepu Medical Recent Developments
Table 86. Hengrui Medicine Basic Information List
Table 87. Hengrui Medicine Description and Business Overview
Table 88. Hengrui Medicine Oral Antidiabetic Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Hengrui Medicine (2019-2024)
Table 90. Hengrui Medicine Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Oral Antidiabetic Drugs Downstream Customers
Table 94. Oral Antidiabetic Drugs Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oral Antidiabetic Drugs Product Picture
Figure 2. Global Oral Antidiabetic Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Oral Antidiabetic Drugs Report Years Considered
Figure 5. Global Oral Antidiabetic Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Antidiabetic Drugs Revenue in 2023
Figure 7. Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Sulfonylureas Picture
Figure 9. Meglitinides Picture
Figure 10. Alpha-glucosidase inhibitors Picture
Figure 11. Global Oral Antidiabetic Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Oral Antidiabetic Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Clinics
Figure 15. Product Picture of Others
Figure 16. Global Oral Antidiabetic Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oral Antidiabetic Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Oral Antidiabetic Drugs Sales Value (%), (2019-2030)
Figure 29. United States Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. China Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. China Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. India Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. India Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Oral Antidiabetic Drugs Industrial Chain
Figure 51. Oral Antidiabetic Drugs Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Table 1. Oral Antidiabetic Drugs Market Trends
Table 2. Oral Antidiabetic Drugs Market Drivers & Opportunity
Table 3. Oral Antidiabetic Drugs Market Challenges
Table 4. Oral Antidiabetic Drugs Market Restraints
Table 5. Global Oral Antidiabetic Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oral Antidiabetic Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oral Antidiabetic Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oral Antidiabetic Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Oral Antidiabetic Drugs
Table 10. Global Oral Antidiabetic Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oral Antidiabetic Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oral Antidiabetic Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oral Antidiabetic Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oral Antidiabetic Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oral Antidiabetic Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oral Antidiabetic Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oral Antidiabetic Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oral Antidiabetic Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Oral Antidiabetic Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oral Antidiabetic Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oral Antidiabetic Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oral Antidiabetic Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly Basic Information List
Table 32. Eli Lilly Description and Business Overview
Table 33. Eli Lilly Oral Antidiabetic Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Eli Lilly (2019-2024)
Table 35. Eli Lilly Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Oral Antidiabetic Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Biocon Basic Information List
Table 42. Biocon Description and Business Overview
Table 43. Biocon Oral Antidiabetic Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Biocon (2019-2024)
Table 45. Biocon Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Oral Antidiabetic Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Sanofi (2019-2024)
Table 50. Sanofi Recent Developments
Table 51. Sunpharma Basic Information List
Table 52. Sunpharma Description and Business Overview
Table 53. Sunpharma Oral Antidiabetic Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Sunpharma (2019-2024)
Table 55. Sunpharma Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Oral Antidiabetic Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Novo Nordisk Basic Information List
Table 62. Novo Nordisk Description and Business Overview
Table 63. Novo Nordisk Oral Antidiabetic Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Novo Nordisk (2019-2024)
Table 65. Novo Nordisk Recent Developments
Table 66. Merck Basic Information List
Table 67. Merck Description and Business Overview
Table 68. Merck Oral Antidiabetic Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Merck (2019-2024)
Table 70. Merck Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Oral Antidiabetic Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. Huadong Medicine Co.,Ltd. Basic Information List
Table 77. Huadong Medicine Co.,Ltd. Description and Business Overview
Table 78. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Huadong Medicine Co.,Ltd. (2019-2024)
Table 80. Huadong Medicine Co.,Ltd. Recent Developments
Table 81. Lepu Medical Basic Information List
Table 82. Lepu Medical Description and Business Overview
Table 83. Lepu Medical Oral Antidiabetic Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Lepu Medical (2019-2024)
Table 85. Lepu Medical Recent Developments
Table 86. Hengrui Medicine Basic Information List
Table 87. Hengrui Medicine Description and Business Overview
Table 88. Hengrui Medicine Oral Antidiabetic Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oral Antidiabetic Drugs Business of Hengrui Medicine (2019-2024)
Table 90. Hengrui Medicine Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Oral Antidiabetic Drugs Downstream Customers
Table 94. Oral Antidiabetic Drugs Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oral Antidiabetic Drugs Product Picture
Figure 2. Global Oral Antidiabetic Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Oral Antidiabetic Drugs Report Years Considered
Figure 5. Global Oral Antidiabetic Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Antidiabetic Drugs Revenue in 2023
Figure 7. Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Sulfonylureas Picture
Figure 9. Meglitinides Picture
Figure 10. Alpha-glucosidase inhibitors Picture
Figure 11. Global Oral Antidiabetic Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Oral Antidiabetic Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Clinics
Figure 15. Product Picture of Others
Figure 16. Global Oral Antidiabetic Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oral Antidiabetic Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Oral Antidiabetic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Oral Antidiabetic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Oral Antidiabetic Drugs Sales Value (%), (2019-2030)
Figure 29. United States Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. China Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. China Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. India Oral Antidiabetic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Oral Antidiabetic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. India Oral Antidiabetic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Oral Antidiabetic Drugs Industrial Chain
Figure 51. Oral Antidiabetic Drugs Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232